Skip to main content
Erschienen in: Journal of Neurology 5/2013

01.05.2013 | Original Communication

Historical changes of seasonal differences in the frequency of multiple sclerosis clinical attacks: a multicenter study

verfasst von: Gerardo Iuliano, Cavit Boz, Edgardo Cristiano, Pierre Duquette, Alessandra Lugaresi, Celia Oreja-Guevara, Vincent Van Pesch

Erschienen in: Journal of Neurology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Previous papers show discordant patterns of monthly and seasonal differences in the frequency of multiple sclerosis relapses. Attacks are more often reported in spring and summer, but there are many variations, mainly as to summer peaks. This paper, an MSBase collaboration substudy, reports multiple series of relapses from 1980 to 2010, comparing ultradecennal trends of seasonal frequency of attacks in different countries. The MSBase international database was searched for relapses in series recording patient histories from 1980 up to 2010. The number of relapses by month was stratified by decade (1981–1990, 1991–2000, 2001–2010). Positive spring versus summer peaks were compared by odds ratios; different series were compared by weighted odds ratio (Peto OR). Decade comparison of the 1990s versus 2000s shows inversion of spring–summer peak (2000s = March; 1990s = July), significant in the whole group (Peto odds ratio = 1.31, CI = 1.10–1.56, p = 0.003) and in Salerno series (OR = 1.97, CI = 1.14–1.40). The global significance persisted also excluding Salerno series (Peto odds ratio = 1.25, CI = 1.04–1.50, p = 0.002). Multicentric data confirm a summer peak of relapses in the 1991–2000 decade, significantly different from the spring peak of 2001–2010. Seasonal frequency of relapses shows long-term variations, so that other factors such as viral epidemics might have more relevance than ultraviolet exposure.
Literatur
1.
Zurück zum Zitat Jin YP, de Pedro-Cuesta J, Soderstrom M, Link H (1999) Incidence of optic neuritis in Stockholm, Sweden, 1990–1995: II. Time and space patterns. Arch Neurol 56(8):975–980PubMedCrossRef Jin YP, de Pedro-Cuesta J, Soderstrom M, Link H (1999) Incidence of optic neuritis in Stockholm, Sweden, 1990–1995: II. Time and space patterns. Arch Neurol 56(8):975–980PubMedCrossRef
2.
Zurück zum Zitat Salvi F, Bartolomei I, Smolensky MH, Lorusso A, Barbarossa E, Malagoni AM, Zamboni P, Manfredini R (2010) A seasonal periodicity in relapses of multiple sclerosis? A single-center, population-based, preliminary study conducted in Bologna, Italy. BMC Neurol 1(10):105CrossRef Salvi F, Bartolomei I, Smolensky MH, Lorusso A, Barbarossa E, Malagoni AM, Zamboni P, Manfredini R (2010) A seasonal periodicity in relapses of multiple sclerosis? A single-center, population-based, preliminary study conducted in Bologna, Italy. BMC Neurol 1(10):105CrossRef
3.
Zurück zum Zitat Jin Y, de Pedro-Cuesta J, Soderstrom M, Stawiarz L, Link H (2000) Seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis. J Neurol Sci 181(1–2):56–64PubMedCrossRef Jin Y, de Pedro-Cuesta J, Soderstrom M, Stawiarz L, Link H (2000) Seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis. J Neurol Sci 181(1–2):56–64PubMedCrossRef
4.
Zurück zum Zitat Bamford CR, Sibley WA, Thies C (1983) Seasonal variation of multiple sclerosis exacerbations in Arizona. Neurology 33(6):697–701PubMedCrossRef Bamford CR, Sibley WA, Thies C (1983) Seasonal variation of multiple sclerosis exacerbations in Arizona. Neurology 33(6):697–701PubMedCrossRef
5.
Zurück zum Zitat Goodkin DE, Hertsgaard D (1989) Seasonal variation of multiple sclerosis exacerbations in North Dakota. Arch Neurol 46(9):1015–1018PubMedCrossRef Goodkin DE, Hertsgaard D (1989) Seasonal variation of multiple sclerosis exacerbations in North Dakota. Arch Neurol 46(9):1015–1018PubMedCrossRef
6.
Zurück zum Zitat Abella-Corral J, Prieto JM, Dapena-Bolaño D, Iglesias-Gómez S, Noya-García M, Lema M (2005) Seasonal variations in the outbreaks in patients with multiple sclerosis. Rev Neurol 40(7):394–396PubMed Abella-Corral J, Prieto JM, Dapena-Bolaño D, Iglesias-Gómez S, Noya-García M, Lema M (2005) Seasonal variations in the outbreaks in patients with multiple sclerosis. Rev Neurol 40(7):394–396PubMed
7.
Zurück zum Zitat Bisgård C (1990) Seasonal variation in disseminated sclerosis. Ugeskr Laeger 152(16):1160–1161PubMed Bisgård C (1990) Seasonal variation in disseminated sclerosis. Ugeskr Laeger 152(16):1160–1161PubMed
8.
Zurück zum Zitat Ogawa G, Mochizuki H, Kanzaki M, Kaida K, Motoyoshi K, Kamakura K (2004) Seasonal variation of multiple sclerosis exacerbations in Japan. Neurol Sci 24(6):417–419PubMedCrossRef Ogawa G, Mochizuki H, Kanzaki M, Kaida K, Motoyoshi K, Kamakura K (2004) Seasonal variation of multiple sclerosis exacerbations in Japan. Neurol Sci 24(6):417–419PubMedCrossRef
9.
Zurück zum Zitat Iuliano G, Napoletano R, Esposito A (2005) Seasonal differences in the frequency of relapse in multiple sclerosis. (article in italian, abstract in english) Riv. It. Neurobiologia II(4):209–212 Iuliano G, Napoletano R, Esposito A (2005) Seasonal differences in the frequency of relapse in multiple sclerosis. (article in italian, abstract in english) Riv. It. Neurobiologia II(4):209–212
10.
Zurück zum Zitat Tremlett H, van der Mei IA, Pittas F, Blizzard L, Paley G, Mesaros D, Woodbaker R, Nunez M, Dwyer T, Taylor BV, Ponsonby AL (2008) Monthly ambient sunlight, infections and relapse rates in multiple sclerosis. Neuroepidemiology 31(4):271–279 (published online first: 30 October 2008)PubMedCrossRef Tremlett H, van der Mei IA, Pittas F, Blizzard L, Paley G, Mesaros D, Woodbaker R, Nunez M, Dwyer T, Taylor BV, Ponsonby AL (2008) Monthly ambient sunlight, infections and relapse rates in multiple sclerosis. Neuroepidemiology 31(4):271–279 (published online first: 30 October 2008)PubMedCrossRef
11.
Zurück zum Zitat Koziol JA, Feng AC (2004) Seasonal variations in exacerbations and MRI parameters in relapsing-remitting multiple sclerosis. Neuroepidemiology 23(5):217–223PubMedCrossRef Koziol JA, Feng AC (2004) Seasonal variations in exacerbations and MRI parameters in relapsing-remitting multiple sclerosis. Neuroepidemiology 23(5):217–223PubMedCrossRef
13.
Zurück zum Zitat Saaroni H, Sigal A, Lejbkowicz I, Miller A (2010) Mediterranean weather conditions and exacerbations of multiple sclerosis. Neuroepidemiology 35(2):142–151 Epub 2010 Jun 23PubMedCrossRef Saaroni H, Sigal A, Lejbkowicz I, Miller A (2010) Mediterranean weather conditions and exacerbations of multiple sclerosis. Neuroepidemiology 35(2):142–151 Epub 2010 Jun 23PubMedCrossRef
14.
Zurück zum Zitat O’Reilly MA, O’Reilly PM (1991) Temporal influences on relapses of multiple sclerosis. Eur Neurol 31(6):391–395PubMedCrossRef O’Reilly MA, O’Reilly PM (1991) Temporal influences on relapses of multiple sclerosis. Eur Neurol 31(6):391–395PubMedCrossRef
15.
Zurück zum Zitat Mealy MA, Newsome S, Greenberg BM, Wingerchuk D, Calabresi P, Levy M (2011) Low serum vitamin D levels and recurrent inflammatory spinal cord disease. Arch Neurol Nov 14. [Epub ahead of print] Mealy MA, Newsome S, Greenberg BM, Wingerchuk D, Calabresi P, Levy M (2011) Low serum vitamin D levels and recurrent inflammatory spinal cord disease. Arch Neurol Nov 14. [Epub ahead of print]
16.
Zurück zum Zitat Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, Dwyer T, Gies P, van der Mei I (2010) Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 68(2):193–203PubMed Simpson S Jr, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, Dwyer T, Gies P, van der Mei I (2010) Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 68(2):193–203PubMed
17.
Zurück zum Zitat Van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, Butzkueven H, McMichael AJ (2007) Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol 254(5):581–590 (published online first: 11 April 2007)PubMedCrossRef Van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, Butzkueven H, McMichael AJ (2007) Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol 254(5):581–590 (published online first: 11 April 2007)PubMedCrossRef
18.
Zurück zum Zitat Davis GE Jr, Lowell WE (2006) Solar cycles and their relationship to human disease and adaptability. Med Hypotheses 67(3):447–461 (published online first: 15 May 2006)PubMedCrossRef Davis GE Jr, Lowell WE (2006) Solar cycles and their relationship to human disease and adaptability. Med Hypotheses 67(3):447–461 (published online first: 15 May 2006)PubMedCrossRef
19.
Zurück zum Zitat Freedman DM, Dosemeci M, Alavanja MC (2000) Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med 57(6):418–421PubMedCrossRef Freedman DM, Dosemeci M, Alavanja MC (2000) Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med 57(6):418–421PubMedCrossRef
20.
Zurück zum Zitat McMichael AJ, Hall AJ (1997) Does immunosuppressive ultraviolet radiation explain the latitude gradient for multiple sclerosis? Epidemiology 8(6):642–645PubMed McMichael AJ, Hall AJ (1997) Does immunosuppressive ultraviolet radiation explain the latitude gradient for multiple sclerosis? Epidemiology 8(6):642–645PubMed
21.
Zurück zum Zitat Hutter CD, Laing P (1996) Multiple sclerosis: sunlight, diet, immunology and aetiology. Med Hypotheses 46(2):67–74PubMedCrossRef Hutter CD, Laing P (1996) Multiple sclerosis: sunlight, diet, immunology and aetiology. Med Hypotheses 46(2):67–74PubMedCrossRef
22.
23.
Zurück zum Zitat Lauer K (1994) The risk of multiple sclerosis in the USA in relation to sociogeographic features: a factor-analytic study. J Clin Epidemiol 47(1):43–48PubMedCrossRef Lauer K (1994) The risk of multiple sclerosis in the USA in relation to sociogeographic features: a factor-analytic study. J Clin Epidemiol 47(1):43–48PubMedCrossRef
24.
Zurück zum Zitat Gray OM, Jolley D, Zwanikken C, Trojano M, Grand-Maison F, Duquette P et al (2009) Temporal variation of onset of relapses in multiple sclerosis: results from the Northern and Southern Hemispheres in the Msbase registry (abstract). Neurology 72(suppl 3):8–27 Gray OM, Jolley D, Zwanikken C, Trojano M, Grand-Maison F, Duquette P et al (2009) Temporal variation of onset of relapses in multiple sclerosis: results from the Northern and Southern Hemispheres in the Msbase registry (abstract). Neurology 72(suppl 3):8–27
25.
Zurück zum Zitat O. Gray, D. Jolley, K. Gibson, M. Trojano, C. Zwanikken, F. Grand’Maison, P. Duquette, G. Izquierdo, P. et al (2009) Onset of relapses in multiple sclerosis: the effect of seasonal change in both the northern and southern hemisphere (abstract). Multiple Sclerosis 15 (suppl 2): p532, s158 O. Gray, D. Jolley, K. Gibson, M. Trojano, C. Zwanikken, F. Grand’Maison, P. Duquette, G. Izquierdo, P. et al (2009) Onset of relapses in multiple sclerosis: the effect of seasonal change in both the northern and southern hemisphere (abstract). Multiple Sclerosis 15 (suppl 2): p532, s158
26.
Zurück zum Zitat Meier DS, Balashov KE, Healy B, Weiner HL, Guttmann CRG (2010) Seasonal prevalence of MS disease activity. Neurology 75:799–806PubMedCrossRef Meier DS, Balashov KE, Healy B, Weiner HL, Guttmann CRG (2010) Seasonal prevalence of MS disease activity. Neurology 75:799–806PubMedCrossRef
28.
Zurück zum Zitat Butzkueven H, Boz C, Chapman J et al (2010) MSBase, an international platform dedicated to linking multiple sclerosis researchers—observational plan, 6th edition. The MSBase Foundation Ltd, Parkville Butzkueven H, Boz C, Chapman J et al (2010) MSBase, an international platform dedicated to linking multiple sclerosis researchers—observational plan, 6th edition. The MSBase Foundation Ltd, Parkville
29.
Zurück zum Zitat Polman CH, Reingold SC, Edan C et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”. Ann Neurol 58(6):840–846PubMedCrossRef Polman CH, Reingold SC, Edan C et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”. Ann Neurol 58(6):840–846PubMedCrossRef
Metadaten
Titel
Historical changes of seasonal differences in the frequency of multiple sclerosis clinical attacks: a multicenter study
verfasst von
Gerardo Iuliano
Cavit Boz
Edgardo Cristiano
Pierre Duquette
Alessandra Lugaresi
Celia Oreja-Guevara
Vincent Van Pesch
Publikationsdatum
01.05.2013
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 5/2013
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-012-6785-y

Weitere Artikel der Ausgabe 5/2013

Journal of Neurology 5/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.